A Study to Evaluate The Prevalence of Morbidity in Covid 19 and Vaccination Status Among Patients Admitted in A Tertiary Care Institute, Puducherry

Abstract

COVID-19 is a mild to moderate illness caused by SARS-CoV-2, however it can cause life-threatening consequences in some cases. The study looks at how a COVID-19 immunization campaign in Tamil Nadu and Pondicherry reduced incidence, hospitalizations, and mortality. The purpose of this study is to compare the effectiveness of covid vaccination and its morbidities among covid 19 patients, as well as to determine the relationship between covid vaccination and morbidity prevalence among covid 19 patients. For this study, a descriptive cross-sectional research design was used. This study includes individuals aged 20 to 60 years who have been diagnosed with Covid -19 of all cycles and post-Covid patients with cardio-respiratory problems. Approximately 67.6% of those vaccinated had no comorbidities, 26.3% had Diabetes, 16.7% had Hypertension, 0.8% had Hypothroidism, and 0.4% had Epilepsy. In terms of Oxygen Support, nearly half of the patients (44%) required it, whereas less than 5% (4.4%) required mechanical ventilation. More than three-quarters of the patients (85.3%) were cured when they were discharged. Nearly half of the patients (50% had a CORADS score of 6). The majority of patients (38.7%) had a CT Severity Score of 9-15. The value of biophysiological variables increased by 20-25%. The mortality rate among vaccinated patients is 8 (10.7) and 101 (15.2), respectively. In conclusion, getting vaccinated can limit viral transmissions and prevent the virus from evolving into new types that can be lethal.